tiprankstipranks
Trending News
More News >
Prime Medicine, Inc. (PRME)
:PRME
US Market
Advertisement

Prime Medicine, Inc. (PRME) Ownership - Who Owns Prime Medicine, Inc.?

Compare
833 Followers

Prime Medicine, Inc. (PRME) Ownership Overview

49.24%5.59%18.52%8.87%17.76%
49.24% Insiders
18.52% Other Institutional Investors
8.87% ETFs
17.76% Public Companies and
Individual Investors
The ownership structure of Prime Medicine, Inc. (PRME) stock is a mix of institutional, retail, and individual investors. Approximately 32.99% of the company’s stock is owned by Institutional Investors, 49.24% is owned by Insiders, and 17.76% is owned by Public Companies and Individual Investors.
The ownership structure of Prime Medicine, Inc. (PRME) stock is a mix of institutional, retail, and individual investors. Approximately 24.12% of the company’s stock is owned by Institutional Investors, 49.24% is owned by Insiders, and 8.87% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Aug 05, 2025
xxxxxxxxxxxxx
$4950000
Aug 01, 2025
xxxxxxxxxxxxx
$9999990
Aug 01, 2025
xxxxxxxxxxxxx
$9999990
Aug 01, 2025
xxxxxxxxxxxxx
$9999990

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Sep 30, 2025
xxxxxxxxxxxxx
$16620000
Sep 30, 2025
xxxxxxxxxxxxx
$16633750
Sep 30, 2025
xxxxxxxxxxxxx
$26315000
Sep 30, 2025
xxxxxxxxxxxxx
$30347294

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
20,240,945Insider11.21%67,402,347
18,502,974Insider10.25%61,614,903
18,486,894Insider10.24%61,561,357
18,486,894Insider10.24%61,561,357
5,477,851Institution3.03%18,241,244
5,305,679Insider2.94%17,667,911
5,236,789Institution2.90%17,438,507
4,723,919Institution2.62%15,730,650
4,361,078Insider2.42%14,522,390
3,663,137Institution2.03%12,198,246

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
3,569,787Institution1.98%11,887,391
3,048,060Institution1.69%10,150,040
680,325Institution0.38%2,265,482
666,122Institution0.37%2,218,186
328,993Institution0.18%1,095,547
314,562Institution0.17%1,047,491
286,684Institution0.16%954,658
284,770Institution0.16%948,284
200,000Institution0.11%666,000
178,871Institution0.10%595,640

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
5,009,248Institution2.78%16,680,796
2,981,248Institution1.65%16,516,114
1,847,313Institution1.02%6,151,552
698,976Institution0.39%3,872,327
680,000Institution0.38%2,910,666
634,450Institution0.35%2,112,719
595,221Institution0.33%1,982,086
562,587Institution0.31%1,873,415
358,346Institution0.20%1,985,237
346,807Institution0.19%1,359,483

FAQ

Who Owns Prime Medicine, Inc. (PRME)?
According to the latest TipRanks data, approximately 18.52% of the company's stock is held by institutional investors, 49.24% is held by insiders, and 17.76% is held by retail investors.
    What percentage of Prime Medicine, Inc. (PRME) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 18.52% of Prime Medicine, Inc. (PRME) stock is held by institutional investors.
      What percentage of Prime Medicine, Inc. (PRME) stock is held by retail investors?
      According to the latest TipRanks data, approximately 17.76% of Prime Medicine, Inc. (PRME) stock is held by retail investors.
        Who owns the most shares of Prime Medicine, Inc. (PRME)?
        David R. Liu owns the most shares of Prime Medicine, Inc. (PRME).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis